clinical decision support

By Heather Mack April 18, 2017
Santa Cruz, California-based Murj, developer of a digital data collection platform for implantable cardiac devices, has officially emerged from stealth mode. Backed by $4.5 million in venture funding, the company wants to streamline workflow for clinicians grappling with increasingly more data from heart-monitoring devices, both remotely and in the office. Murj’s SaaS platform aims to replace...
By Jonah Comstock April 13, 2017
Boston Children’s Hospital held its second Innovation and Digital Health Accelerator Innovator’s Showcase yesterday, inviting more than 20 startups working with the hospital in some capacity to network and share their work with each other. At the event, the company also kicked off its newest open innovation challenge, which focuses specifically on clinical decision support.  “The idea there is we...
By Jonah Comstock April 10, 2017
New York City-based Spring, which offers clinical decision support for providers around behavioral health, has raised $1.5 million in seed funding. William K. Warren Foundation, a philanthropic organization associated with the St. Francis Health System, and serial entrepreneur Kevin Ryan (founder of Gilt and Business Insider). Additional contributions came from RRE Ventures, North Sound Ventures...
By Heather Mack April 10, 2017
Irvine, California-based Masimo, makers of a suite of non-invasive patient monitoring devices and sensors, has expanded the capabilities of its connected platform to allow physicians to view more data, more clearly and in the configuration that works best for them. Clinicians get a lot of data from Masimo’s bedside monitoring devices – which include the recently FDA-cleared forehead sensor,...
By Heather Mack March 13, 2017
Copenhagen, Denmark-based Leo Innovation Lab announced a $5.5 million Series A and seed funding round that will go to five startups around the world, ranging from mobile app makers to AI platform providers. Leo Innovation Lab sprung out of Danish pharmaceutical company Leo Pharma in 2015 and was established to develop long-term strategies aimed at improving multiple aspects of everyday life for...
By Heather Mack January 12, 2017
Cincinnati, Ohio based PatientPoint, which makes engagement platforms and apps for providers and patients, is collaborating with the American Heart Association to provide educational resources on heart health and stroke prevention to doctors and physicians at the point of care. PatientPoint will act as an extension of the American Heart Association’s informational efforts, leveraging its network...
By Heather Mack January 4, 2017
The United States Department of Defense has tapped healthcare communication company Vocera Communications to deploy San Jose, California-based Vocera’s system in the Army’s Medical Command facilities around the world. The $14 million contract – Vocera’s largest to date – will equip Army care team members with the company’s wireless, hands-free clinical communications platform in 23 facilities....
By Heather Mack September 1, 2016
Physicians are up to their ears in information, eager for new, technologically advanced solutions, and struggling to keep up with healthcare reform. At least, that’s the sense researchers from the Decision Resource Group got from a recent survey of doctors. For the study, Taking the Pulse, the group surveyed 2,994 US physicians, finding that – in an era of a collective shift towards value rather...
By Aditi Pai October 29, 2015
The next generation of digital health offerings will use machine learning to treat patients more effectively, but it's still a decade away, according to Vinod Khosla, founder of Khosla Ventures, who spoke at Partners HealthCare's Connected Health Symposium in Boston this week. Khosla said no one can deny medicine has improved over the past 50 years, but it could be much better. One area ripe for...
By MHN Staff October 8, 2015
By Bradley Merrill Thompson If I invented an unprecedented mobile technology for treating tennis elbow, the law would require me to do substantial and expensive clinical trials before bringing it to market. In my last post, I argued that the FDA regulatory system is structurally biased against new technology, including novel software, even if it is low risk.  By law, any medical device that is...